Awareness towards an increasing concern during pregnancy: maternal and perinatal outcomes of women with cancer.

BACKGROUND: Increased incidence of cancer in women of childbearing age and improvements on treatment for preserving fertility have led to higher frequency of pregnancy during or after cancer treatment. OBJECTIVE: This study aimed to describe maternal and perinatal outcomes associated with cancer and pregnancy and, as a secondary analysis, to compare outcomes of women with active disease and with remission before pregnancy. STUDY DESIGN: We performed a retrospective study of women followed up at a referral center owing to a history of cancer or cancer diagnosed during pregnancy. Data on sociodemographic information, obstetrical history, types of neoplasia, treatments offered, antenatal follow-up, and maternal and perinatal outcomes were retrieved from medical chart review. A descriptive analysis was performed and a comparison among women with active and nonactive disease was performed using Student t-test and chi-square test. RESULTS: A total of 66 women were included in a 5-year period. The most frequent types of cancer were breast (33%), hematologic (21%), brain (11%), cervical (9%), and ovarian (5%) cancers. There were 39 participants (59%) who had active disease and 26 who received oncological treatment during pregnancy, and 23 (34.8%) had a vaginal delivery. There were 4 women who needed intensive care unit admission postpartum. A total of 18 (29.5%) deliveries were at term, most newborns (59%) with adequate weight for gestational age and only 1 had Apgar score lower than 7 in the fifth minute of life. There was 1 stillbirth. The active invasive cancer during pregnancy group showed a higher rate of preterm birth and lower birthweight with significant statistical difference (P=.03 and P<.01, respectively). CONCLUSION: Breast cancer was the most frequent type of cancer in our cohort. Most deliveries were preterm, with adequate birthweight. Women with active cancer are more likely to have a preterm childbirth and newborns with lower birthweight.

Case-control study of shock index among women who did and did not receive blood transfusions due to postpartum hemorrhage.

OBJECTIVE: To compare shock index (SI) values between women who required blood transfusion due to postpartum hemorrhage (PPH) and women who did not. METHODS: In a case-control study, clinical data were assessed from the medical records of women requiring blood transfusion for PPH at a center in Brazil between 2012 and 2015 (n=105). A control group was randomly selected from women who did not receive blood transfusion (n=129). RESULTS: Compared with women who did not receive a transfusion after delivery, women who did receive one had significantly higher SI values 10 minutes after delivery (0.81 ± 0.27 vs 0.72 ± 0.16; P=0.012), at 30 minutes (0.83 ± 0.26 vs 0.71 ± 0.15; P<0.001), and at 2 hours (0.84 ± 0.27 vs 0.70 ± 0.14; P=0.032). For vaginal deliveries, SI values were significantly different at 30 minutes (0.88 ± 0.26 vs 0.71 ± 0.14; P<0.001) and 2 hours (0.90 ± 0.23 vs 0.72 ± 0.14; P=0.001). No significant differences were found for cesarean delivery. CONCLUSION: The SI might be useful to identify early vital sign changes due to PPH. Increased SI values were associated with need for transfusion in vaginal deliveries.